BETTER THERAPEUTICS INC (BTTX) Stock Price & Overview
NASDAQ:BTTX • US08773T1043
The current stock price of BTTX is 0.0446 USD. Today BTTX is up by 27.43%. In the past month the price decreased by -78.14%. In the past year, price decreased by -95.79%.
BTTX Key Statistics
- Market Cap
- 2.224M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.15
- Dividend Yield
- N/A
BTTX Stock Performance
BTTX Stock Chart
BTTX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BTTX. When comparing the yearly performance of all stocks, BTTX is a bad performer in the overall market: 99.79% of all stocks are doing better.
BTTX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BTTX. BTTX may be in some trouble as it scores bad on both profitability and health.
BTTX Earnings
BTTX Forecast & Estimates
8 analysts have analysed BTTX and the average price target is 5.36 USD. This implies a price increase of 11906.73% is expected in the next year compared to the current price of 0.0446.
For the next year, analysts expect an EPS growth of 50.82% and a revenue growth -100% for BTTX
BTTX Groups
Sector & Classification
BTTX Financial Highlights
Over the last trailing twelve months BTTX reported a non-GAAP Earnings per Share(EPS) of -1.15. The EPS increased by 43.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -294.55% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTTX Ownership
BTTX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 21.23 | 30.56B | ||
| WAY | WAYSTAR HOLDING CORP | 16.1 | 5.085B | ||
| DOCS | DOXIMITY INC-CLASS A | 15.4 | 4.982B | ||
| HTFL | HEARTFLOW INC | N/A | 2.033B | ||
| CERT | CERTARA INC | 14.43 | 1.152B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.088B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 227.73 | 1.083B | ||
| SDGR | SCHRODINGER INC | N/A | 922.875M | ||
| TDOC | TELADOC HEALTH INC | N/A | 909.84M | ||
| PHR | PHREESIA INC | 18.94 | 745.787M | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 5.64 | 709.12M | ||
| HSTM | HEALTHSTREAM INC | 28.37 | 637.112M | ||
| EVH | EVOLENT HEALTH INC - A | 12.92 | 391.856M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BTTX
Company Profile
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. The company is headquartered in San Francisco, California and currently employs 54 full-time employees. The company went IPO on 2021-01-08. The firm is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The firm's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.
Company Info
BETTER THERAPEUTICS INC
548 Market St. #49404
San Francisco CALIFORNIA US
CEO: Suying Liu
Employees: 54
Phone: 14158872311
BETTER THERAPEUTICS INC / BTTX FAQ
What does BTTX do?
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. The company is headquartered in San Francisco, California and currently employs 54 full-time employees. The company went IPO on 2021-01-08. The firm is engaged in developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases. Its lead PDT product candidate, BT-001, is an investigational prescription digital therapy for the treatment of T2D. The investigational therapy is delivered via software that provides a tailored experience to patients designed to help them address the underlying causes of T2D by making meaningful, sustainable behavioral changes. The BT-001 investigational therapy is rooted in the well-studied, gold standard of behavioral modification therapies, cognitive behavioral therapy (CBT). The firm's platform consists of three behavioral therapy, treatment plans and personalization. Its behavioral therapy consists of lessons, skill- building modules, and a mechanism for goal setting. Its treatment plan is the primary engagement interface for patients.
What is the stock price of BETTER THERAPEUTICS INC today?
The current stock price of BTTX is 0.0446 USD. The price increased by 27.43% in the last trading session.
What is the dividend status of BETTER THERAPEUTICS INC?
BTTX does not pay a dividend.
How is the ChartMill rating for BETTER THERAPEUTICS INC?
BTTX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists BTTX stock?
BTTX stock is listed on the Nasdaq exchange.
Would investing in BETTER THERAPEUTICS INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BTTX.
Can you provide the market cap for BETTER THERAPEUTICS INC?
BETTER THERAPEUTICS INC (BTTX) has a market capitalization of 2.22M USD. This makes BTTX a Nano Cap stock.